Deranged hepatocyte intracellular Ca2+ homeostasis and the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma

ES Ali, GY Rychkov, GJ Barritt - Cell calcium, 2019 - Elsevier
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths in
men, and the sixth in women. Non-alcoholic fatty liver disease (NAFLD) is now one of the …

Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis

C Jiang, G Cheng, M Liao, J Huang - World Journal of Surgical Oncology, 2021 - Springer
Background There is still some debate as to whether transcatheter arterial
chemoembolization (TACE) plus radiofrequency ablation (RFA) is better than TACE or RFA …

Interim efficacy and safety of PD-1 inhibitors in preventing recurrence of hepatocellular carcinoma after interventional therapy

W Qiao, Q Wang, C Hu, Y Zhang, J Li, Y Sun… - Frontiers in …, 2022 - frontiersin.org
Introduction Locoregional interventional therapy including transcatheter arterial
chemoembolization (TACE) and ablation are the current standard of treatment for early-to …

Recurrence of Hepatocellular Carcinoma in Patients with Low Albumin-Bilirubin Grade in TACE Combined with Ablation: A Random Forest Cox Predictive Model

Y Xiong, W Qiao, T Mei, K Li, R Jin… - Journal of Hepatocellular …, 2024 - Taylor & Francis
Purpose The aim of our study was to investigate the relationship between albumin-bilirubin
(ALBI) grade and recurrence in patients who underwent TACE sequential ablation. We …

[HTML][HTML] Update on percutaneous local ablative procedures for the treatment of hepatocellular carcinoma

L Luerken, M Haimerl, M Doppler… - RöFo-Fortschritte auf …, 2022 - thieme-connect.com
Hintergrund Das hepatozelluläre Karzinom (HCC) ist das fünfthäufigste Tumorleiden
weltweit. Da viele HCCs bereits zum Zeitpunkt der Erstdiagnose nicht resektabel sind …

Combined radiofrequency ablation or microwave ablation with transarterial chemoembolization can increase efficiency in intermediate-stage hepatocellular …

Y Yang, H Yu, L Qi, C Liu, Y Feng, J Qi… - International Journal of …, 2022 - Taylor & Francis
Objectives Radiofrequency ablation (RFA) and microwave ablation (MWA) are widely used
in combination with transarterial chemoembolization (TACE) for intermediate-stage …

Locoregional therapies in the treatment of 3-to 5-cm hepatocellular carcinoma: critical review of the literature

S Young, J Golzarian - American Journal of Roentgenology, 2020 - Am Roentgen Ray Soc
OBJECTIVE. Treatment options for hepatocellular carcinoma (HCC) continue to expand.
However, given the complexity of the patients including factors such as codominant cirrhosis …

Comparison of combined transarterial chemoembolization and ablations in patients with hepatocellular carcinoma: a systematic review and meta-analysis

P Keshavarz, SS Raman - Abdominal Radiology, 2022 - Springer
Purpose This systematic review and meta-analysis compares the efficacy of three
combination therapies, including transarterial chemoembolization (TACE) with …

Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of …

L Chen, X Kan, T Sun, Y Ren, Y Cao, L Yan… - BMC …, 2020 - Springer
Background Transarterial chemoembolization (TACE), radiofrequency ablation (RFA), and
iodine 125 seeds implantation are optional treatments for hepatocellular carcinoma (HCC) …

Targeting Ca2+ Signaling in the Initiation, Promotion and Progression of Hepatocellular Carcinoma

ES Ali, GY Rychkov, GJ Barritt - Cancers, 2020 - mdpi.com
Simple Summary Liver cancer (hepatocellular carcinoma) is a significant health burden
worldwide. It is often not detected until at an advanced stage when there are few treatment …